((Studies,Studies,Identified,FibrinDeposits),3.9318256327243257)
((Consideration,Consideration,IsCriticalFor,EffectiveManagementOfCancerProgression),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularDepositsAsDistinctFeatures),3.9318256327243257)
((SinonasalDiseaseSymptoms,SinonasalDiseaseSymptoms,IsWith,IncreasedAsthmaSeverity),3.9318256327243257)
((Obesity,Obesity,IsAssociatedWith,SeverityOfDisease),3.9318256327243257)
((ThrombinActivity,ThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents),3.9318256327243257)
((NasalCorticosteroidTreatment,NasalCorticosteroidTreatment,IsIn,Asthma),3.9318256327243257)
((Wording,Wording,Should,FurthermoreShouldEvidencebased),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularFibrinDepositsAsFeatures),3.9318256327243257)
((SpecialConsideration,SpecialConsideration,Is,Critical),3.9318256327243257)
((DirectThrombinInhibitor,DirectThrombinInhibitor,IsIn,Mice),3.9318256327243257)
((Consideration,Consideration,IsCriticalFor,Management),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,Deposits),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsAsFeatures),3.9318256327243257)
((SpecialConsideration,SpecialConsideration,IsCriticalFor,EffectiveManagement),3.9318256327243257)
((Studies,Studies,Identified,FibrinDepositsAsDistinctFeaturesOfMice),3.9318256327243257)
((DiagnosticCriteria,DiagnosticCriteria,Avoid,AttributionOfCausality),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularDeposits),3.9318256327243257)
((Obesity,Obesity,IsAssociatedWith,IncreasedSeverity),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice),3.9318256327243257)
((SinonasalDisease,SinonasalDisease,CanContributeTo,AsthmaControl),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsAsFeaturesOfMice),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeatures),3.9318256327243257)
((Studies,Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularDepositsAsFeaturesOfMice),3.9318256327243257)
((Increase,Increase,TranslatesTo,BreastCancerMetastasis),3.9318256327243257)
((Wording,Wording,Should,ShouldEvidencebased),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeaturesOfMice),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,FibrinDeposits),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsFeatures),3.9318256327243257)
((ItEndeavor,ItEndeavor,Review,ICD11BetaDraftForDefinitionOfOverweightSubstantialRevision),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,FibrinDepositsAsDistinctFeaturesOfMice),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice),3.9318256327243257)
((ObesityassociatedInflammation,ObesityassociatedInflammation,Promotes,Progression),3.9318256327243257)
((Studies,Studies,Identified,DepositsAsFeaturesOfMice),3.9318256327243257)
((Purpose,Purpose,Affects,ResponseToCorticosteroidTreatmentInAsthma),3.9318256327243257)
((Obesity,Obesity,IsAssociatedWith,Severity),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsFeatures),3.9318256327243257)
((Consideration,Consideration,IsCriticalFor,EffectiveManagement),3.9318256327243257)
((Studies,Studies,Identified,FibrinDepositsAsDistinctFeatures),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeatures),3.9318256327243257)
((HepaticInflammation,HepaticInflammation,IsWith,ReducedMacrophageCountsWithinWhiteAdiposeTissue),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice),3.9318256327243257)
((DiagnosticCriteria,DiagnosticCriteria,Should,ShouldDescriptive),3.9318256327243257)
((ItEndeavor,ItEndeavor,Review,CurrentICD11BetaDraftForDefinitionOfOverweightSubstantialRevision),3.9318256327243257)
((Obesity,Obesity,IsAssociatedWith,IncreasedSeverityOfDisease),3.9318256327243257)
((Studies,Studies,Identified,DepositsWithinAdiposeTissueAsFeatures),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularFibrinDeposits),3.9318256327243257)
((ThrombinActivity,ThrombinActivity,Underlies,ThromboembolicEvents),3.9318256327243257)
((SpecialConsideration,SpecialConsideration,IsCriticalFor,Management),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularDeposits),3.9318256327243257)
((Studies,Studies,Identified,FibrinDepositsAsFeatures),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,FibrinDepositsAsFeaturesOfMice),3.9318256327243257)
((SinonasalDisease,SinonasalDisease,CanContributeTo,PoorAsthmaControl),3.9318256327243257)
((Increase,Increase,TranslatesIn,GMCSF),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsFeatures),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularDepositsAsDistinctFeaturesOfMice),3.9318256327243257)
((LinkObesity,LinkObesity,IsWith,IncreasedPrevalenceOfSinonasalDisease),3.9318256327243257)
((Studies,Studies,Identified,DepositsAsDistinctFeatures),3.9318256327243257)
((ElevatedThrombinActivity,ElevatedThrombinActivity,Underlies,ThromboembolicEvents),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures),3.9318256327243257)
((ElevatedThrombinActivity,ElevatedThrombinActivity,Underlies,ObesitylinkedThromboembolicEvents),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularFibrinDepositsAsFeaturesOfMice),3.9318256327243257)
((Increase,Increase,TranslatesTo,IncreasedBreastCancerMetastasis),3.9318256327243257)
((Consideration,Consideration,IsCriticalFor,ManagementOfCancerProgression),3.9318256327243257)
((Pathologies,Pathologies,IsIn,ObesePatients),3.9318256327243257)
((Inflammation,Inflammation,Promotes,Progression),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularDepositsAsFeatures),3.9318256327243257)
((Inflammation,Inflammation,Promotes,MetastaticProgression),3.9318256327243257)
((Purpose,Purpose,Affects,ResponseToNasalCorticosteroidTreatmentInAsthma),3.9318256327243257)
((Pathologies,Pathologies,Targeting,Thrombin),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,ExtravascularDepositsAsDistinctFeatures),3.9318256327243257)
((SpecialConsideration,SpecialConsideration,IsCriticalFor,ManagementOfCancerProgression),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeatures),3.9318256327243257)
((Studies,Studies,Identified,DepositsAsDistinctFeaturesOfMice),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularFibrinDeposits),3.9318256327243257)
((ObesityassociatedInflammation,ObesityassociatedInflammation,Promotes,MetastaticProgression),3.9318256327243257)
((Disease,Disease,CanContributeTo,PoorAsthmaControl),3.9318256327243257)
((SpecialConsideration,SpecialConsideration,IsCriticalFor,EffectiveManagementOfCancerProgression),3.9318256327243257)
((Patients,Patients,IsWith,Obesity),3.9318256327243257)
((Consideration,Consideration,Is,Critical),3.9318256327243257)
((Studies,Studies,Identified,DepositsAsFeatures),3.9318256327243257)
((Studies,Studies,Identified,FibrinDepositsAsFeaturesOfMice),3.9318256327243257)
((Obesity,Obesity,Causes,LungNeutrophilia),3.9318256327243257)
((Obesity,Obesity,Is,Associated),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeatures),3.9318256327243257)
((Obesity,Obesity,IsAssociatedWith,IncreasedSeverityOfSinonasalDisease),3.9318256327243257)
((Studies,Studies,Identified,DepositsWithinAdiposeTissueAsFeaturesOfMice),3.9318256327243257)
((Obesity,Obesity,IsAssociatedWith,SeverityOfSinonasalDisease),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissue),3.9318256327243257)
((Association,Association,AreConsistentAcross,BMIGroups),3.9318256327243257)
((DirectThrombinInhibitor,DirectThrombinInhibitor,IsWith,EstablishedObesity),3.9318256327243257)
((Studies,Studies,Identified,Deposits),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsWithinAdiposeTissueAsDistinctFeaturesOfMice),3.9318256327243257)
((Studies,Studies,Identified,ExtravascularFibrinDepositsAsDistinctFeaturesOfMice),3.9318256327243257)
((Studies,Studies,Identified,DepositsWithinAdiposeTissueAsDistinctFeatures),3.9318256327243257)
((Studies,Studies,Identified,DepositsWithinAdiposeTissue),3.9318256327243257)
((Disease,Disease,CanContributeTo,AsthmaControl),3.9318256327243257)
((ImmunohistochemicalStudies,ImmunohistochemicalStudies,Identified,DepositsAsDistinctFeaturesOfMice),3.9318256327243257)
